| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| Revenue | $30.13B | +3.4% |
| R&D Expense | $2.25B | -4.4% |
| SG&A Expense | $4.87B | -5.6% |
| Operating Income | $2.19B | +4.8% |
| Interest Expense | $777.0M | +9.6% |
| Pre-tax Income | $2.95B | +32.4% |
| Income Tax | $374.0M | +82.4% |
| Net Income | $2.58B | +27.4% |
| EPS (Basic) | $1.95 |
| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.85B | +247.7% |
| Accounts Receivable | $3.55B | +2.0% |
| Inventory | $7.81B | +69.5% |
| Current Assets | $33.46B | +76.6% |
| Total Assets | $71.26B | +24.7% |
| Current Liabilities | $25.97B | +18.7% |
| Long-term Debt | $17.66B | +51.0% |
| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.34B | -2.0% |
| Investing Cash Flow | -$53.0M | +98.4% |
| Financing Cash Flow | $6.28B | +561.3% |
| +25.0% |
| EPS (Diluted) | $1.93 | +25.3% |
| Stockholders' Equity |
| $24.82B |
| +17.2% |